期刊文献+

丙酸氟替卡松联合盐酸班布特罗治疗儿童哮喘疗效观察

Efficacy of fluticasome propinate combined with bambuterol hydrochloride in treatment of asthma in children
下载PDF
导出
摘要 目的:观察丙酸氟替卡松加盐酸班布特罗防治儿童哮喘的疗效。方法:将32例中度哮喘患儿随机分成两组。治疗组18例采用丙酸氟替卡松吸入加盐酸班布特罗口服,对照组14例单用丙酸氟替卡松吸入,观察两组治疗前及治疗4、8、12周后日夜间哮喘症状评分,对22例患儿于治疗前及治疗12周后监测最大呼气峰流速值(PEF)。结果:两组日夜间哮喘症状评分于治疗4、8、12周后均有显著改善,且在以后的治疗中得到持续改善,治疗组优于对照组(P<0.01);两组PEF于治疗后也有显著改善(P<0.01),但差异无显著性(P>0.05)。结论:丙酸氟替卡松吸入加盐酸班布特罗口服治疗儿童哮喘疗效显著。 Objective:To observes the therapeutic effect of fluticasone propinate inhalation plus bambuterol hydrochloride in the prevention and treatment of asthma in children.Methods:Thirty-two children with moderate asthma were divided into two groups at random.Treatment group(18 cases) were administered fluticasone propinate inhalation plus bambuterol hydrochloride.Control group(14 cases) were given fluticasone propinate inhalation only.The daytime and night asthma symptom scores were observed before treatment and 4 weeks,8 weeks and 12 weeks after treatment.The peak expiratory flow(PEF) of 22 cases before treatment and 12 weeks after treatment were easured.Results:The scores of daytime,night asthma symptom 4 weeks,8 weeks and 12 weeks after treatment were significantly different from those before treatment(P<0.01),and the symptoms gradually improved with the treatment,which was more obvious in the treatment group than in the control group(P<0.01).PEF were significantly different between pre-treatment and 12 weeks after treatment(P<0.01),but treatment group and control group was no sighifcantly diffrent(P>0.05).Conclusions:Fluticasone propinate inhalation combined with bambuterol hydrohloride is effective for treatment of asthma in children.
作者 张文娟 孙勇
出处 《蚌埠医学院学报》 CAS 2005年第4期315-316,共2页 Journal of Bengbu Medical College
关键词 哮喘 丙酸氟替卡松 盐酸班布特罗 儿童 asthma fluticasone propinate bambuterol hydrochloride child
  • 相关文献

参考文献9

二级参考文献23

  • 1曹玲,陈育智,谭立玮,李硕,张淳,罗雁青,赵京.长期吸入丙酸倍氯松的哮喘儿童肾上腺皮质功能的观察[J].中华儿科杂志,1997,35(2):88-90. 被引量:24
  • 2陈育智 华云汉.儿童哮喘诊断治疗常规[J].中华结核和呼吸杂志,1993,16:10-10.
  • 3-.中华医学会呼吸病学分会支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗、疗效判断标准及教育和管理方案)[J].中华结核和呼吸杂志,1997,20:261-264.
  • 4Global initiative for asthma: global strategy for asthma management and prevention NHILBI/WHO workshop report[ J ]. NIH publication No. 02, 2002,3659.
  • 5Barnes PJ, Pedersen S, Busse WW.Efficacy and safety of inhaled corticosteroids [ J ]. Am J Respir Crit Care Med, 1998,157 : S1 - 53.
  • 6Todd GRG, Acerini C, Ross- Russell R,et al. National survey (UK) of acute adrenal crisis due to inhaled corticosteroids [ J ]. J Allergy Clin Immunol,2002,109(1 pt2) :S252.
  • 7Mcivor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma[J]. Am J Respir Crit Care Med,1988,158:924 - 930.
  • 8Jenkins C, Woolcock AJ, Saarelainen P, et al.Salmetero/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma[J].Respir Med, 2000,94:715:723.
  • 9Storms W, Michele TM, Knorr B, et al.Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients age > or = 6 years[J]. Clin Exp Allergy,2001,31:77 -78.
  • 10Stempel DA, Stanford RH, McLaughlin T, et al. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast [ J ]. Respir Med, 2001,95 : 227-234.

共引文献6037

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部